X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Parkinsons Disease

期刊標題檢索 PARKINSONS DIS- 最新評論: Just like a crazy person, this publication is the weirdest I've ever s... (2023-12-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Parkinsons Disease]您好,您是該頁面的第 11450 位訪客。

期刊簡介
期刊名稱Parkinsons Disease Parkinsons Disease
LetPub Score
5.2
50 ratings
Rate

Reputation
5.9

Influence
3.8

Speed
9.1

期刊簡稱PARKINSONS DIS-US
ISSN2090-8083
h-index37
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.800.7530.841
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Neuroscience (miscellaneous)
Q111 / 49
Category: Neuroscience
Subcategory: Psychiatry and Mental Health
Q2161 / 567
Category: Neuroscience
Subcategory: Neurology (clinical)
Q2119 / 400

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.
官方網站https://www.hindawi.com/journals/pd/
在線稿件提交
開放訪問Yes
出版商Hindawi Limited
主題領域CLINICAL NEUROLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數26每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( USD2000; )
APC waiver:Check Notes
Other charges: No
Keywords: parkinson's disease
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CLINICAL NEUROLOGYSCIEQ3160/277
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2090-8083%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 18 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Parkinsons Disease】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE644441
    BIOMATERIALS595457
    Frontiers in Pharmacology499420
    BIOMEDICINE & PHARMACOTHERAPY498553
    JOURNAL OF ETHNOPHARMACOLOGY488987
    Journal of Materials Chemistry B476132
    Frontiers in Immunology460679
    COLLOIDS AND SURFACES B-BIOINTERFACES419429
    COMPUTERS IN BIOLOGY AND MEDICINE418712
    Frontiers in Oncology415226
  •  

    Parkinsons Disease Parkinsons Disease
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Parkinsons Disease] 的評論撰寫評論
作者: 桃花子辰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 22:58:31 評論於
Just like a crazy person, this publication is the weirdest I've ever seen. After I submitted my article, a stranger emailed me asking for a work email address. I provided one, but the editor never sent anything to that address. Instead, they bombarded my personal email with messages, saying my article title was the same as another article and demanding I change it. They asked me to send the revised title by email, which I found bizarre. At first, I thought it was a scam, but then I realized it wasn't. They kept insisting on changes even though my title was completely different from the other article's. It was like dealing with a crazy person, wasting half a month. I withdrew my submission! I will never submit to that trashy publication under this publishing house again!
(0) 讚! | 桃花子辰

作者: 桃花子辰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 12:27:29 評論於
Psychiatric journal
(0) 讚! | 桃花子辰

作者: Martin3


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2022-07-29 10:53:41 評論於
Half a month after submission, it will be reviewed. Two months later, it will be returned for major revisions. In one month, supplementary experiments will be conducted and returned. Minor revisions will be made in half a month, and it will be accepted one week after resubmission.
(0) 讚! | Martin3

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:06:45 評論於
Whether the subject matter of the manuscript is suitable for the scope defined by the journal; the readership of the journal; the review and publication timeline of the journal
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:41:21 評論於
Journals in the research field that are recognized for higher acceptance rates or better development of manuscript quality; considerations may include acceptance rates and review speed, among others, if time constraints are a concern
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:11:11 評論於
Two journals are equally important, how do you choose which one to submit to?
(0) 讚! | 平原文波

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 17:15:47 評論於
Are there any principles for selecting a journal?
(0) 讚! | 深渊兴业

作者: Nicola Locke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-15 22:29:47 評論於
This is the first sci, it is a pity that it was accepted in June, and then the IF dropped by 2 points, which is embarrassing
(0) 讚! | Nicola Locke

作者: Derrick Truman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-06 08:24:16 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: My first Sci paper was accepted, coming back to express my gratitude and hoping to help others. Submitted on 2019-10-20, the status after submission was under review.
In early January 2020, major revisions were required with feedback from two reviewers. One recommended rejection and pointed out many issues, while the other suggested minor revisions, mainly focusing on formatting errors and adding a reference. The final decision from the editor was major revisions. It took a whole week to respond to each comment and submit the revised manuscript.
By the end of January 2020, the editor requested minor revisions, followed by formatting changes and uploading the revised manuscript. The acceptance notification came by the end of February 2020.
The memory is vivid as I received the acceptance during the school closure due to the epidemic, lying in bed. I was thrilled and immediately uploaded the final draft and images. By April 10, it was searchable on PubMed.
Overall, based on the journal name alone, it is worth submitting to. I believe this journal has great potential. One flaw may be the repeated requests for emails and publications from participating authors after submission, which can be a bit awkward
(0) 讚! | Derrick Truman

作者: NARY


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-31 10:30:01 評論於
The amount of articles accepted in the year is a bit less, in fact not so good.
(0) 讚! | NARY

作者: 碧桃逸致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-31 10:24:47 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Experience sharing: The number of articles accepted annually is a bit low, not as good as it seems
(0) 讚! | 碧桃逸致

作者: 东慧小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-28 11:39:15 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Experience Sharing: It is a relatively new journal, so the submission process should be acceptable. The submission process is relatively simple, the review speed is also quite fast, and the acceptance rate listed on the website is 46%
(0) 讚! | 东慧小公主

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-06-07 22:45:56 評論於
Review speed: 2.0 | Submission success rate: 75.0
Sharing experience: The specialty journal of PD disease was newly selected for SCI in 2014, showing great potential, and is expected to reach around 3 points in the future
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Parkinsons Disease] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*